"Biotech industrial crops are plants genetically engineered to produce industrial products, including drugs, food, biologics, cosmetics, industrial and research chemicals. Recombinant DNA techniques are used to locate and isolate genes of r industrial interest. These "transgenes" are then inserted into a crop plant using one of several standard protocols. The resulting industrial plant then produces the protein product encoded by the transgenic as if it were one of its own naturally occurring genes. This book captures how genetically modified crops can be exploited for conventional agriculture and greener biopharming for pharmaceutical industries. Pharmaceuticals and industrial compounds from the perspective of their co-existence with conventional agriculture. Such plant-made pharmaceuticals and plant made industrial products rely on exciting scientific and technological breakthroughs and promise new opportunities for the agricultural sector, getting rid of novel risks. The management of the externalities and of the possible unintended economic effects that arise in this context is critical and poses difficult questions for regulators. Conversion of most of the solid transgenic industrial crops by products such as plant oil lignocellulosic materials into liquid biobased energy-fuels, this can be said to be a technology of agro-industrial biomass. Considering the increasing world population and explosive growth of emerging economies that create escalating demands for agricultural, industrial and health products, the book covers how Innovative biotechnology can expand the markets for agricultural producers worldwide, reduce environmental degradation, and provide alternatives to fossil carbon-derived products and energy. Aspect of entrepreneurial biotechnology and bioprospecting was also covered"--
Be the first to review this book!
